SCHEMBL6480883

SCHEMBL6480883

CN(C)c1ccc2cc(-c3nc4cc(F)ccc4o3)cnc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ APP P05067 6/20 0.47
▸ EGFR P00533 1/20 0.43
▸ PDGFRB P09619 3/20 0.42
▸ PDGFRA P16234 3/20 0.42
▸ UTRN P46939 3/20 0.42
▸ GRK2 P25098 1/20 0.41
▸ GRK5 P34947 1/20 0.41
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6491771 0.87 NPC1 (0.56) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL6483701 0.74 UTRN (0.48) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL30943188 0.70 RAB9A (0.66) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL2139147 0.70 RAB9A (0.66) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL24037863 0.70 PTPN2 (0.50) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL16739382 0.69 EGFR (0.48) NPC1RAB9ACASP3RXFP1APP
SCHEMBL11226194 0.69 MAPT (0.55) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL12808067 0.69 UTRN (0.52) NPC1RAB9AAPPUTRNESR1
SCHEMBL11246114 0.69 RAB9A (0.77) NPC1RAB9AMEN1CASP3KMT2A
SCHEMBL25028049 0.69 NPC1 (0.72) NPC1RAB9AMEN1CASP3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP NPC1 147/4885RAB9A 1787/4885MEN1 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback